Search

Novocure Ltd

Fermé

SecteurSoins de santé

15.54 -1.83

Résumé

Variation du prix de l'action

24h

Actuel

Min

15.78

Max

15.96

Chiffres clés

By Trading Economics

Revenu

55M

-16M

Ventes

9.5M

184M

BPA

-0.13

Marge bénéficiaire

-8.529

Employés

1,605

EBITDA

53M

-11M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+86.24% upside

Dividendes

By Acuity

Prochains Résultats

29 oct. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

79M

1.9B

Ouverture précédente

17.37

Clôture précédente

15.54

Sentiment de l'Actualité

By Acuity

55%

45%

250 / 339 Classement par Healthcare

Novocure Ltd Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

24 sept. 2026, 20:07 UTC

Novocure Ltd's shares fell sharply, continuing a decline since Wednesday's close, amid broader market weakness and routine fluctuations throughout the session.

21 sept. 2026, 19:16 UTC

Novocure Ltd shares fell sharply, trading below their 20-day moving average and around the midpoint of their one-month trading range.

18 sept. 2026, 23:36 UTC

Novocure Ltd is trading modestly higher in after-market hours, recovering from a decline earlier in the day but remaining below its 20-day moving average.

17 sept. 2026, 19:51 UTC

Novocure Ltd is trading higher amid a broader market rally, boosted by strong labor market data and a positive Philadelphia Fed Manufacturing Index.

16 sept. 2026, 23:06 UTC

Novocure Ltd has gained modestly in after-market trading, recovering from earlier lows but remains below its 20-day moving average.

15 sept. 2026, 19:26 UTC

Novocure Ltd. shares are advancing, rebounding from an earlier low, after three consecutive sessions of gains. The stock remains below its 20-day moving average.

14 sept. 2026, 20:21 UTC

Novocure Ltd shares are higher in after-market hours, continuing a trend of daily gains. No specific news was identified to explain the movement.

11 sept. 2026, 19:36 UTC

Novocure shares are trading higher, buoyed by positive sentiment in the health care equipment sector and broader market dynamics despite some volatility earlier in the session.

10 sept. 2026, 19:46 UTC

Novocure Ltd. shares are lower, continuing a three-session decline amid broader market pressure from the European Central Bank's interest rate hike and inflation warnings.

9 sept. 2026, 23:06 UTC

Novocure Ltd. shares are lower in after-market trading, continuing a three-session decline and remaining below their 20-day moving average. No specific news was identified.

8 sept. 2026, 22:26 UTC

Shares of Novocure Ltd. are higher in after-market trading, fluctuating within a narrow range since Tuesday's close and remaining near the lower end of their one-month range.

2 sept. 2026, 20:08 UTC

News

Novocure Ltd is trading higher as it prepares for two investor events, including chats at the Wells Fargo and Morgan Stanley healthcare conferences.

1 sept. 2026, 19:11 UTC

News

Novocure Ltd shares are lower following a data breach affecting over 1,400 U.S. records, disclosed in a regulatory filing earlier today.

28 août 2026, 20:07 UTC

Novocure Ltd. shares are lower today, pulled back from earlier gains amid rising U.S. Treasury yields impacting broader equity markets.

27 août 2026, 22:01 UTC

Novocure Ltd. shares are lower in after-market hours, reversing a three-session upward trend and moving below the 20-day moving average.

26 août 2026, 20:08 UTC

Novocure Ltd's shares are higher today, continuing an upward trend. The stock is trading above its 20-day moving average and near its one-month range high.

25 août 2026, 20:07 UTC

Novocure Ltd shares are higher today, reversing three days of declines. Easing Treasury yields and lower oil prices have supported overall market sentiment.

24 août 2026, 21:01 UTC

Novocure Ltd. shares are higher in after-market hours, continuing a positive move since Monday's close and trading above the 20-day moving average.

21 août 2026, 23:41 UTC

In after-market trading, Novocure Ltd shares moved higher, reaching the upper end of their one-month trading range, 5.40% above the 20-day moving average.

20 août 2026, 19:16 UTC

Novocure shares are lower today, having reached a session low earlier. No specific company news was identified to explain the decline.

19 août 2026, 23:11 UTC

Novocure Ltd shares closed higher in after-market trading, recovering from earlier lows and finishing above their 20-day moving average. No specific news was identified.

17 août 2026, 19:56 UTC

Novocure Ltd. shares are trading higher, rebounding from recent declines and remaining above the 20-day moving average, indicating a shift in momentum.

15 août 2026, 00:01 UTC

Novocure Ltd. shares are higher in after-market trading, showing notable strength since Friday's close and currently above the 20-day moving average.

14 août 2026, 23:21 UTC

Novocure Ltd shares are higher in after-market trading, reversing a three-session decline. No specific company news was identified to explain this movement.

13 août 2026, 21:01 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a shift in sentiment despite being above the 20-day moving average.

12 août 2026, 19:41 UTC

Novocure Ltd. shares are lower today, reversing a trend of higher daily closes since Tuesday. Earlier in the session, the stock rebounded from a session high.

11 août 2026, 20:06 UTC

Novocure Ltd's shares are advancing, remaining above the 20-day moving average amid strong momentum. No specific company news has been identified for the price movement.

10 août 2026, 21:01 UTC

Novocure Ltd shares are higher in after-market trading, supported by strong performance above the 20-day moving average and within the one-month trading range.

8 août 2026, 00:01 UTC

Novocure Ltd. shares were roughly flat in after-market hours. The stock is near the lower end of its one-month range, despite being above its 20-day average.

7 août 2026, 23:11 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a decline since Friday's close and remaining near the lower end of their one-month range.

Comparaison

Variation de prix

Novocure Ltd prévision

Objectif de Prix

By TipRanks

86.24% hausse

Prévisions sur 12 Mois

Moyen 29.5 USD  86.24%

Haut 52 USD

Bas 17 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

4 ratings

2

Achat

2

Maintien

0

Vente

Sentiment

By Acuity

250 / 339Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.